InvestorsHub Logo
icon url

hoffmann6383

01/21/22 2:50 PM

#437503 RE: exwannabe #437498

Nonsensical assertion



What he meant by 60 was 450-500 per year.

From their own PR:

The Company anticipates that Phase 1A alone will be able to manufacture DCVax-L products for 45-50 patients per month, or 450-500 patients per year...



Source: https://nwbio.com/northwest-biotherapeutics-announces-mhra-approval-of-license-for-gmp-manufacturing-at-sawston-uk-facility/
icon url

highwayman4life

01/21/22 3:21 PM

#437524 RE: exwannabe #437498

Completley false assertion yet again!! Keep Trying